D₃-creatine (D₃Cr) dilution emerges as a robust biomarker for assessing total body skeletal muscle mass, revealing critical insights into muscle function and performance across the lifespan. A recent study involving 895 adults, segmented into younger (30-69 years) and older (70+ years) cohorts, demonstrated significant age-related declines in D₃Cr muscle mass, particularly in men, where the decline accelerated from −0.5% per year in young adults to −1.4% per year in the oldest-old. This decline correlated with decreases in leg strength and walking speed, underscoring the intricate relationship between muscle mass and functional performance.

The findings indicate that while men experience a progressive decline in muscle mass alongside functional capabilities, women exhibit a more stable D₃Cr muscle mass from young adulthood onward, despite facing greater age-related declines in strength, power, and cardiorespiratory fitness (VO₂ peak). This suggests that the mechanisms underlying muscle function may differ by sex, with implications for targeted interventions. The study highlights that declines in muscle mass may not fully account for functional deterioration, particularly in older women, emphasizing the need for comprehensive strategies to maintain muscle health.

The implications of this research are significant for the field of longevity science. By establishing a clearer link between muscle mass and functional decline, it shifts the focus towards the preservation and enhancement of muscle mass throughout adulthood as a critical component of healthspan interventions. This could inform future drug development and therapeutic strategies aimed at mitigating age-related muscle loss, ultimately enhancing quality of life in aging populations.

Source: academic.oup.com